期刊文献+

经皮冠状动脉介入术血清C反应蛋白的变化 被引量:2

Changes of C Reactive Protein Level in Patients with Coronary Heart Disease after Percutaneous Coronary Intervention
下载PDF
导出
摘要 目的:探讨经皮冠状动脉介入治疗术(PCI)后患者血清C反应蛋白(CRP)的变化。方法:随机选取行PCI的冠心病患者76例,分别于术前5 min、术后48 h、1月及6月测定血清CRP水平。结果:PCI术后48 h CRP水平明显高于术前5 min,有显著性差异(P<0.01);术后1月CRP水平较术前5 min明显下降(P<0.05)。结论:PCI术可能在短期内触发并加重冠状动脉炎症,术后1月恢复正常;术后CRP水平持续或再次升高,提示患者病情不稳定。 Objective: To observe the change of C reactive protein (CRP) level after percutaneous coronary intervention (PCI) and to explore the relationship between CRP and clinical state in patients with coronary heart disease(CHD). Method Seventy - six patients with CHD were treated with PCI. The serum levels of CRP were measured by ELISA at 5 min before PCI, and the 48th hour, the first mouth, the sixth mouth after PCI. Results The serum level of CRP at the 48th hour after PCI was higher than that before PCI ( P 〈 0.01 ) , and the CRP level at the first mouth after PCI was lower than that before PCI( P 〈 0.05 ). However, the CRP level at the sixth month after PCI was higher than that before PCI (P 〈 0.05 ). Conclusions PCI is likely to trigger and aggravate coronary artery inflammation in short - term and this change recovers to normal at the first month after PCI. The lesion in CHD may be unstable if the serum level of CRP continuously increases or elevates again.
出处 《郧阳医学院学报》 2008年第2期143-144,147,共3页 Journal of Yunyang Medical College
关键词 冠心病 经皮冠状动脉介入治疗术 C反应蛋白 Coronary heart disease Percutaneous coronary intervention C reactive protein
  • 相关文献

参考文献8

二级参考文献18

  • 1汤蓓.C反应蛋白在急性冠脉综合征预后评判中的价值[J].心脑血管病防治,2004,4(4):23-25. 被引量:8
  • 2刘海波,高润霖,陈在嘉,姚康宝,陈纪林,杨跃进,乔树宾,徐义枢.不稳定性心绞痛患者冠状动脉造影形态学特点及其意义[J].中国循环杂志,1996,11(1):3-5. 被引量:32
  • 3急性心肌梗塞溶栓疗法参考方案(1996年7月修订)[J].中华心血管病杂志,1996,24(5):328-329. 被引量:1321
  • 4[1]Crea F, Biasucci LM, Buffon A, et al. Role of inflammation in the pathogenesis of unstable coronary artery disease. Am J Cardiol, 1997,80:10E-16E.
  • 5[2]Stromme JH, Johansen O, Brekke M, et al. Markers of myocardial injury in blood following PTCA: a comparison of CKMB, cardiospecific troponin T and troponin I. Scand J Clin Lab Invest, 1998,58:683-689.
  • 6[3]Haverkate F. Are C-reactive protin and fibrinogen risk factor? In: Vander Wall E.E et al. (eds), Vascular medicine. Netherlands, Kluwer Academic, 1997.13-21.
  • 7[4]Liuzzo G, Biasucci LM, Gallimore R, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med, 1994,331:417-424.
  • 8[5]Ridker PM, Cushman M, Slampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med, 1997,336:937-939.
  • 9[6]Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med, 1997,336:973-979.
  • 10Luc G,Bard JM,Juhan-vague I,et al.C-reactive protein, interleukin-6,and fibrinogen as predictors of coronary heart disease:the PRIME Study[J].Arterioscler Thromb Vasc Biol,2003,23(7):1 255-1 261.

共引文献384

同被引文献19

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部